SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer | MicrobiomeTrials← Back to trialsNCT07883005
SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2031-11-01
Enrollment target: 288 participants Locations- University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Esophageal Squamous Cell CarcinomaImmunotherapyBiomarkers
To evaluate the efficacy and safety of adebrelimab with or without induction chemotherapy followed by concurrent chemora…
Fuzhou, ChinaEst. completion Dec 2027
Head and Neck CancerHead and Neck Squamous Cell CarcinomaParanasal Sinus NeoplasmsNasopharyngeal CarcinomaOropharyngeal Squamous Cell Carcinoma
Hypopharyngeal Cancer
Carcinoma of Larynx
Oral Squamous Cell Carcinoma
Salivary Gland Cancer
Adenoid Cystic Carcinoma
Prostate Cancer
Metastatic Castration Resistant Prostate Cancer
Background:
Head and neck cancers (HNCs) account for about 5% of all cancers worldwide. They grow in the mouth, throat,…
Bethesda, United StatesEst. completion Oct 1, 2036
Carcinoma, NeuroendocrineTumor, NeuroendocrineTumors, NeuroendocrineNeuroendocrine; CarcinomaSmall Cell; Receptors
Background:
High-grade neuroendocrine carcinomas (HGNEC) are cancers that develop in different parts of the body, inclu…
Bethesda, United StatesEst. completion Jul 30, 2027